Under the terms of the cash deal, Pfizer will pay $65.60 a share upfront and a contingent value right worth up to $20.65 a share
The post Metsera says no to Novo; accepts Pfizer’s new acquisition offer of $10bn appeared first on Arabian Business: Latest News on the Middle East, Real Estate, Finance, and More.
Source: Arabian Business
Full Article: Metsera says no to Novo; accepts Pfizer’s new acquisition offer of bn
